Loading company…
Orphazyme develops biopharmaceutical treatments for rare diseases and protein aggregation disorders.
Founded in 2009 and based in Copenhagen, Denmark, Orphazyme develops treatments for rare diseases, including therapies related to protein aggregation. Its work has included enzyme replacement therapies. Anders Hinsby is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in